Our Strategy & Impact

People Behind the Progress

It takes teamwork to bring new treatments to cancer patients. Scientists, patients, and donors make it possible for us to create lifesaving therapies. Thanks to our community, we continue to fund groundbreaking scientific studies leading to the next great discoveries. We launch clinical trials that give patients new options and hope. And we bring all of us closer to a world free from the fear of cancer.

Read more below about the important people behind the progress at CRI.

All Stories

Page 7 of 11
  • Hyam Levitsky, M.D.

    Hyam Levitsky Bridges Academic-Industry Divide with New Position

    As head of cancer immunology experimental medicine at Roche and as professor at The Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Dr. Hyam I. Levitsky is in a unique position to facilitate academic-industry partnerships that will advance the development of cancer immunotherapies.
  • Katharina Kreymborg, Ph.D.

    Meet the YP Fellow: Katharina Kreymborg, Ph.D.

    Katharina Kreymborg, recipient of CRI's first Young Philanthropists Postdoctoral Fellowship award, is looking to understand the role of T cell costimulatory molecules in cancer immunity.
  • Ralph Steinman, M.D.

    Ralph Steinman on Dendritic Cells and Cancer Immunotherapy

    Ralph Steinman, M.D., of the Rockefeller University in New York, discusses his pioneering research on the role of dendritic cells in the immune system's response to cancer.
  • Louise and Peter Moseychuk

    Battles with Cancer Inspire Couple to Give to CRI

    For the last eight years, the Moseychuks have been annual donors to Cancer Research Institute, with the confidence that their support would help the organization's immunological approach to confronting cancer.
  • Jeffrey Chou, M.D., Ph.D.

    Jeffrey Chou and New Directions in Colorectal Cancer Research

    Colorectal cancer is the second-leading cause of cancer death in the United States. New studies from this CRI scientist may help to make this type of cancer more vulnerable to attack by the immune system, and open up new treatment options for patients.
  • Matthew Youngman, Ph.D.

    Dr. Matthew Youngman on Cancer and Aging

    As we age, we become more prone to disease caused by infection and cancer. Dr. Youngman is exploring the link between aging and the immune system, and his work could lead to new immunotherapies that boost protection against cancer.
  • Diane and Don Holmes

    Giving for a Time Beyond Their Lives

    NASA scientific software developers Diane and Don set up a charitable remainder trust with CRI because they believe in its philosophy: that our own bodies are capable of creating an immune response to cancer.
  • Padmanee Sharma

    CRI Investigator Dr. Padmanee Sharma Tests New Prostate Cancer Immunotherapies

    Dr. Sharma's translational research focuses on learning how to apply immune-based therapeutic strategies to manipulate components of the human immune system to lead to tumor regression.